Inhibition of DNA Methylation by 1-hr Infusion of 5-aza-2'-Deoxycytidine (Decitabine) x 10 Days (M-F) With Escalating Doses of Sub-Q Pegylated (PEG) Interferon-alfa 2B (PEG-Intron): A Phase I Study With Molecular Correlates.
Phase of Trial: Phase I
Latest Information Update: 19 Jul 2011
At a glance
- Drugs Decitabine; Peginterferon alfa-2b
- Indications Cancer
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 19 Jul 2011 Actual initiation date (Apr 2009) added as reported by ClinicalTrials.gov
- 19 Jul 2011 Planned end date (Oct 2010) added as reported by ClinicalTrials.gov.
- 17 Nov 2008 Integrated ClinicalTrials.gov record.